Hospital
Kaiser Foundation Health Plan of Washington
Kaiser Foundation Health Plan of Washington was paid $484K by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is 74177, Computed tomography, abdomen and pelvis; with contrast material — 17% of everything it billed.
33Billing provider infoKAISER FOUNDATION HEALTH PLAN OF WASHINGTON
SEATTLE, WA 98112
SEATTLE, WA 98112
33aNPI1861522088assigned 03/06/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$484K
24GClaims56,102
24DCodes billed49
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Washington
Rank by total paid#44 of 49
Median peer was paid$20.06M
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,297 | $40K | |
| 2019 | 5,980 | $40K | |
| 2020 | 7,042 | $50K | |
| 2021 | 9,865 | $104K | |
| 2022 | 11,668 | $100K | |
| 2023 | 10,316 | $104K | |
| 2024incomplete | 5,934 | $45K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 17% | 544 | 516 | $82K |
| 71046 | Radiologic examination, chest; 2 views | 13% | 1,945 | 1,792 | $63K |
| 80053 | Comprehensive metabolic panel | 8.0% | 6,259 | 5,327 | $39K |
| 76830 | Ultrasound, transvaginal | 7.2% | 397 | 384 | $35K |
| 36415 | Collection of venous blood by venipuncture | 6.4% | 10,134 | 8,973 | $31K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.9% | 8,210 | 6,785 | $29K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 4.9% | 1,441 | 1,290 | $24K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 4.4% | 426 | 411 | $21K |
| 83690 | 3.4% | 2,976 | 2,754 | $17K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 3.4% | 191 | 182 | $17K |
| 84484 | 2.8% | 1,902 | 1,530 | $13K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2.5% | 299 | 299 | $12K |
37 more codes
| 80048 | Basic metabolic panel (calcium, ionized) | 2.3% | 1,783 | $11K |
| 71045 | Radiologic examination, chest; single view | 2.1% | 344 | $10K |
| 87210 | 1.8% | 1,691 | $9K | |
| 80178 | 1.7% | 693 | $8K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.7% | 385 | $8K |
| 81001 | 1.5% | 3,584 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 1,099 | $6K |
| 86140 | 1.3% | 1,280 | $6K | |
| 81025 | 1.1% | 3,146 | $5K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 232 | $4K |
| 80305 | <1% | 483 | $3K | |
| 85610 | <1% | 1,361 | $3K | |
| 81003 | <1% | 1,828 | $3K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 21 | $3K |
| 85379 | <1% | 425 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 119 | $2K |
| 83880 | <1% | 119 | $1K | |
| 73630 | <1% | 43 | $1K | |
| 76536 | <1% | 16 | $1K | |
| 82565 | <1% | 220 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 14 | $923.62 |
| 76642 | <1% | 14 | $912.34 | |
| 83605 | <1% | 117 | $907.67 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,628 | $379.77 |
| 86850 | <1% | 70 | $365.06 | |
| 86901 | <1% | 169 | $353.91 | |
| 86900 | <1% | 87 | $321.63 | |
| 84702 | <1% | 35 | $297.03 | |
| 83735 | <1% | 104 | $290.87 | |
| 93971 | <1% | 12 | $275.98 | |
| 85027 | <1% | 30 | $137.33 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 14 | $119.76 |
| 84132 | <1% | 15 | $32.13 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 51 | $30.31 |
| 84460 | <1% | 16 | $26.60 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 32 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 98 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBARLOW, MICHELLE (MANAGER)
Parent organizationKAISER FOUNDATION HEALTH PLAN OF WASHINGTON
| Provider | Location | Paid |
|---|---|---|
| Kaiser Foundation Health Plan of Washington | Renton, WA | $11.76M |
| Kaiser Foundation Health Plan of Washington | Renton, WA | $7.54M |
| Kaiser Foundation Health Plan of Washington | Renton, WA | $1.30M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.